Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO
Iambic Therapeutics, a biotech that has won favour not just with investors but has also garnered support from pharma companies,…
News
Roche’s Tecentriq snags FDA label expansion in type of colon cancer
Bio-Techne opens GMP small molecule facility in Bristol, UK
Biohaven partners with Ono in $100m IgG degrader deal
Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout
Change lifestyle before giving children weight loss medication, WHO says
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
10x Genomics and Fred Hutch partner on cancer technologies
